April 2019 FDA Recall Drug by Advanced Pharma Inc.
D-1251-2019 - Sub-potency
This Class II drug recall was voluntarily initiated by Advanced Pharma Inc. on April 26, 2019 for the product Drug. The FDA reported the reason for recall as sub-potency. The product was distributed Nationwide and the recall is currently terminated.
Recall Number: D-1251-2019
Sub-potency
04-26-2019
05-08-2019
560 bags
Recall Profile & Regulatory Data
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
The firm responsible for the recall.
Advanced Pharma Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Method by which the firm first notified the public.
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Distribution Pattern About Distribution Pattern
General area of initial distribution.
General area of initial distribution.
Nationwide in the US
10-30-2019
Product Description About Product Description
Full technical description of the product.
Full technical description of the product.
HYDROmorphone 20 mg/100 mL Injectable Solution, Hydromorphone HCl 20 mg 0.9% Sodium Chloride 100 mL, Sterile single use bag, Compounded Drug, Avella of Houston 9265 Kirby Dr., Houston, TX 77054 (877) 794-0404, NDC: 42852-221-10
Batch or Lot Expiration Information
Lot# Lot: 01/14/19 0215 22110P Exp. 04/29/2019